Blood tests were pending Friday for six to eight patients in Pennsylvania who might have contracted the Zika virus abroad, a state health official said.
A positive test would mark the state’s first documented case from the international Zika epidemic, which has reached across two dozen countries and regions in Central America, South America and the Caribbean. Each of the patients tested in Pennsylvania has traveled recently to one of those areas, said Loren K. Robinson, a deputy secretary in the state Department of Health.
It wasn’t immediately clear how those patients are faring or where they live. Federal privacy rules limit personal details that health agencies can disclose.
“We want to be clear that Zika cannot be transmitted through casual contact,” Dr. Robinson said during a conference call with reporters. She estimated it can take up to two weeks for blood-test results to come through from the Atlanta-based Centers for Disease Control and Prevention.
The virus infects humans through mosquito bites, although researchers have not ruled out transmission through sexual intercourse or blood transfusions. Doctors have diagnosed more than 30 United States residents with Zika over the last year. All those patients are thought to have picked up the bug in outbreak-stricken regions.
Dr. Robinson said she did not know whether any of the people tested in Pennsylvania were pregnant. In Brazil, a Zika outbreak affecting expectant mothers over the past several months has coincided with nearly 4,000 potential cases of microcephaly, which is a congenital condition associated with incomplete brain development. Babies with microcephaly are born with small heads and potential brain damage.
Read More
Health authorities are urging pregnant women to reconsider any travel to epidemic-affected areas until researchers have a better understanding of the virus. The CDC recommends a Zika blood test for pregnant women who visited those areas and show signs of the virus within a couple weeks of their return. Symptoms include fever, rash and joint pain.
“We need to emphasize that women who’ve traveled to the endemic areas should be seeing their ob-gyn and considering a screening,” said Scott Shapiro, the Pennsylvania Medical Society president. “Women who have not traveled — they don’t have the same worries. They’re not going to be exposed unless they travel to those areas.”
Apart from Zika’s possible effects on pregnancy, doctors generally classify it as a mild illness that clears up within a week or so. The CDC has reported no cases transmitted within the continental United States.
Yet both doctors and entomologists caution that could change later this year. A tropical mosquito species identified as Zika’s primary transmitter in humans — the Aedes aegypti — lives in Southern states, reaching as far north as Washington, D.C. Another mosquito species — the Aedes albopictus, or Asian tiger mosquito — might infect people even farther north, including in Pennsylvania, but that potential hazard is limited, scholars said.
“I don’t think in Pennsylvania we would have a massive amount of local transmission happening. I think it would be sporadic if it did happen,” said Jason Rasgon, an associate professor of entomology at Penn State University.
Either way, state workers will closely watch mosquito populations and any disease risk as the weather heats up, Dr. Robinson said. She said health officials will set a specific monitoring plan with the state Department of Environmental Protection. The Americas could see as many as 4 million Zika cases over the next year, according to the World Health Organization.
At the Allegheny County Health Department, medical entomologist Bill Todaro said he expects Zika to join the diseases that public health agencies already test for in mosquito communities. He said Florida and Texas are much more likely than Pennsylvania to see the virus appear in mosquitoes.
“If I had to pick a state where we might see local seeding of Aedes mosquitoes, Pennsylvania would be low down the list,” Mr. Todaro said.
The Associated Press contributed. Adam Smeltz: asmeltz@post-gazette.com, 412-263-2625 or on Twitter @asmeltz.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.